|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1992-11-6
|
|
pubmed:abstractText |
Significant advances in the areas of identification of disease susceptibility genes and gene transfer technologies have fueled new initiatives in cellular engineering as a means for treating metabolic disease. This article utilizes new findings from such work as the blueprint for a discussion of the prospects for gene therapy in diabetes mellitus.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
B
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0733-222X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:geneSymbol |
GLUT-1,
GLUT-2,
GLUT-4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1112-20
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:1369396-Adrenocorticotropic Hormone,
pubmed-meshheading:1369396-Animals,
pubmed-meshheading:1369396-Cell Line,
pubmed-meshheading:1369396-Diabetes Mellitus, Type 1,
pubmed-meshheading:1369396-Diabetes Mellitus, Type 2,
pubmed-meshheading:1369396-Gene Therapy,
pubmed-meshheading:1369396-Glucose,
pubmed-meshheading:1369396-Humans,
pubmed-meshheading:1369396-Insulin Infusion Systems,
pubmed-meshheading:1369396-Insulin Resistance,
pubmed-meshheading:1369396-Insulinoma,
pubmed-meshheading:1369396-Mice,
pubmed-meshheading:1369396-Rats,
pubmed-meshheading:1369396-Transfection
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes.
|
|
pubmed:affiliation |
Gifford Laboratories for Diabetes Research, University of Texas Southwestern Medical Center, Dallas 75235.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
